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o r i g i n a l a r t i c l e
Validation of ICD-9-CM Diagnosis Codes for Surgical Site Infection
and Noninfectious Wound Complications After Mastectomy
Margaret A. Olsen, PhD, MPH;1,2 Kelly E. Ball, BSN, MPH, RN;1 Katelin B. Nickel, MPH;1 Anna E. Wallace, MPH;3
Victoria J. Fraser, MD1
background. Few studies have validated ICD-9-CM diagnosis codes for surgical site infection (SSI), and none have validated coding for
noninfectious wound complications after mastectomy.
objectives. To determine the accuracy of International Classiﬁcation of Diseases, Ninth Revision, Clinical Modiﬁcation (ICD-9-CM)
diagnosis codes in health insurer claims data to identify SSI and noninfectious wound complications, including hematoma, seroma, fat
and tissue necrosis, and dehiscence, after mastectomy.
methods. We reviewed medical records for 275 randomly selected women who were coded in the claims data for mastectomy with or
without immediate breast reconstruction and had an ICD-9-CM diagnosis code for a wound complication within 180 days after surgery. We
calculated the positive predictive value (PPV) to evaluate the accuracy of diagnosis codes in identifying speciﬁc wound complications and the
PPV to determine the accuracy of coding for the breast surgical procedure.
results. The PPV for SSI was 57.5%, or 68.9% if cellulitis-alone was considered an SSI, while the PPV for cellulitis was 82.2%. The PPVs of
individual noninfectious wound complications ranged from 47.8% for fat necrosis to 94.9% for seroma and 96.6% for hematoma. The PPVs for
mastectomy, implant, and autologous ﬂap reconstruction were uniformly high (97.5%–99.2%).
conclusions. Our results suggest that claims data can be used to compare rates of infectious and noninfectious wound complications
after mastectomy across facilities, even though PPVs vary by speciﬁc type of postoperative complication. The accuracy of coding was highest
for cellulitis, hematoma, and seroma, and a composite group of noninfectious complications (fat necrosis, tissue necrosis, or dehiscence).
Infect Control Hosp Epidemiol 2017;38:334–339
Health claims data are useful for retrospective surveillance of
postoperative complications and for tracking complications
across institutions and the spectrum of care. The accuracy of
identiﬁcation depends on the validity of the International
Classiﬁcation of Diseases, Ninth Revision, Clinical Modiﬁcation
(ICD-9-CM) diagnosis codes chosen for surveillance. Results
have been mixed regarding the accuracy of ICD-9-CM diag-
nosis codes for surgical site infection (SSI) after various pro-
cedures. Few studies have validated ICD-9-CM diagnosis
codes for SSI after breast procedures,1–3 and to our knowledge,
no group has validated the coding of noninfectious wound
complications (eg, hematoma, fat necrosis) after mastectomy.
We previously reported on the incidence of SSI4 and non-
infectious wound complications5 after mastectomy using data
from private insurer claims. We used this population to
determine the positive predictive value (PPV) of ICD-9-CM
diagnosis codes to identify infectious and noninfectious
wound complications and ICD-9-CM procedure and CPT-4
codes to identify breast surgical procedures in claims data
compared to medical record review.
methods
From the HealthCore Integrated Research Database, a private
insurer claims database, we established a retrospective cohort
of women 18–64 years of age that had an ICD-9-CM proce-
dure code or a CPT-4 code for mastectomy between January 1,
2004, and August 31, 2009, as described previously (see Sup-
plemental Table 1).4 Newly coded SSIs, cellulitis, hematoma,
seroma, dehiscence, fat necrosis, and tissue necrosis were
identiﬁed by ICD-9-CM diagnosis codes in inpatient and
outpatient facility and provider claims from 2 to 180 days after
mastectomy (day 0 for hematoma), as described previously.4,5
The complication algorithm included diagnosis codes speciﬁc
to breast complications (eg, 611.3 for fat necrosis), and general
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postoperative complications (eg, 998.59 for SSI) (Supple-
mental Tables 2 and 3).
We randomly selected a subset of women with infectious or
noninfectious complications for review of medical records.
We prioritized medical records from hospitals for patients
with an inpatient claim coded for SSI and/or noninfectious
wound complication. If there were no hospitalizations coded
with a complication, we prioritized records from outpatient
facilities, and ﬁnally, we considered medical records from
providers. The medical records were obtained by a third-party
vendor and were redacted of identifying information
before review.
We received records that contained clinical information
spanning the time period of the complication of interest for
132 women coded for SSI and/or cellulitis and 188 women
coded in the claims data for ≥1 noninfectious wound com-
plication. Signs and symptoms of postoperative complications
documented by clinicians were abstracted from the medical
records by a reviewer blinded to the codes in the claims data
(K.E.B.). The Centers for Disease Control and Prevention/
National Healthcare Safety Network (NHSN) deﬁnition was
used to deﬁne SSIs in the medical record; the pre-2010
(including cellulitis as an SSI) and 2010 deﬁnitions (excluding
cellulitis-only) were considered separately.6,7
PPV was calculated as the number of cases conﬁrmed by
medical record review divided by the number identiﬁed
by the claims algorithm. The 95% conﬁdence intervals
were calculated using a ﬁnite population correction factor.
Data management and analyses were performed using SAS
v9.3 (SAS Institute, Cary, NC) and SPSS version 21.0 (IBM
SPSS Statistics, Armonk, NY). This study was approved with a
waiver of informed consent by the Washington University
Human Research Protection Ofﬁce and Quorum Review.
results
We obtained medical records of 275 women coded in the claims
data for mastectomy; 260 records (94.5%) included information
regarding whether mastectomy was performed. The records
showed that 2 women had undergone breast-conserving surgery
rather thanmastectomy, yielding a PPV formastectomy codes of
99.2%. The PPV for laterality of the mastectomy was 94.6%; 244
of 258 were coded correctly in the claims data as unilateral or
bilateral according to medical record review.
In total, 259 records contained sufﬁcient information to
determine whether breast reconstruction was performed and
the type of reconstruction. Of 122 women coded in the
claims for breast expander or implant reconstruction, 119
were conﬁrmed by medical record review (PPV 97.5%). The
records of 48 women included codes for autologous ﬂap
reconstruction, and 47 of these cases were conﬁrmed by
medical record review (PPV, 97.9%).
The PPVs for individual complications are shown in
Table 1. The PPV was 57.5% for SSI using the current NHSN
deﬁnition of SSI (excluding cellulitis-only), but the PPV
increased to 68.9% when the pre-2010 NHSN deﬁnition
including cellulitis-only as SSI was used. The PPVs of indivi-
dual noninfectious wound complications ranged from 47.8%
for fat necrosis to 96.6% for hematoma.
table 1. Positive Predictive Value of Coding in Administrative Claims Data Compared to Medical Record Review to









% (95% Conﬁdence Interval)
SSI and/or cellulitisc 132 91 68.9 (61.4–76.4)
SSI (not including cellulitis) 120 69 57.5 (49.1–65.9)
SSI (not including cellulitis or 998.51) 107 67 62.6 (53.9–71.3)
Cellulitis 45 37 82.2 (71.6–92.9)
Hematoma 58 56 96.6 (92.2–100.9)
Seroma 78 74 94.9 (90.2–99.6)
Dehiscence 41 26 63.4 (49.2–77.6)
Fat necrosis 23 11 47.8 (28.4–67.2)
Tissue necrosis 23 15 65.2 (46.5–84.0)
Dehiscence, fat necrosis,
or tissue necrosis
76 66 86.8 (79.6–94.1)
aWomen could have multiple different complications per the claims data. Of the 188 women coded for noninfectious wound
complications, 157 were coded in the claims data for 1 noninfectious wound complication, 27 were coded for 2 different non-
infectious wound complications, and 4were coded for 3 different noninfectiouswound complications (223 individual noninfectious
complications). In total, 45 women were coded in the claims data for both SSI and a noninfectious wound complication.
bNumber of women coded in the claims data for complication for which the medical record was received with clinical information
spanning the time period of the complication.
cPre-2010 NHSN deﬁnition included cellulitis as SSI. The PPV for this deﬁnition, excluding 998.51, was 75.0 (95%CI, 67.6–82.4).
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The complications documented in the medical record at the
time of false-positive coding for a wound complication are
shown in Table 2. Of 100 discrepancies between the claims
data and medical records among 90 women, 4 (4.0%) had the
correctly coded wound complication at another anatomic site
(eg, port infection, cellulitis), and 81 (81.0%) had a different
breast wound complication recorded in the medical record.
The most common complication noted in the medical records
for women with false-positive coding for SSI was cellulitis,
followed by seroma and noninfectious wound complications.
Of the 13 false-positive SSIs with medical record documenta-
tion of seroma, 11 cases had been coded with the ICD-9-CM
diagnosis code 998.51 (infected postoperative seroma). The
most common error in the coding of noninfectious wound
complications involved incorrect use of a code for a different
wound complication. Of these discrepancies, 24 involved
codes in the claims data for fat or tissue necrosis or dehiscence
with medical record documentation of another of these non-
infectious complications (Table 2). In the case of fat necrosis,
11 of the 12 complications miscoded as fat necrosis had
medical record documentation of tissue necrosis.
discussion
The PPVs of our ICD-9-CM diagnosis code algorithms to
identify infectious and noninfectious complications after
mastectomy were variable but generally showed moderate to
good results. The PPVs of coding for SSI ranged from 58% to
table 2. Summary of Complications That Were Not Conﬁrmed and Complications Documented in the Medical Records
False-Positive Complication





Complication Documented in the Medical Record
at the Time of False-Positive Coding in the Claims Data
SSI (n= 51) 14 Cellulitis
13 Seroma
5 Hematoma
12 Noninfectious wound complication (dehiscence/fat or tissue necrosis)
3 Other infection (port, suture abscess)
4 Nonspeciﬁc complication without speciﬁc indication of breast infection (chronic
inﬂammation/mastitis, pain/swelling/fever, neutropenia)
3 No wound complication (breast revision procedure, drain removal, drainage with
no complication)
Cellulitis (n= 8) 3 SSI
2 Other infection (cellulitis of leg/arm)
2 Seroma
1 Nonspeciﬁc complication without speciﬁc indication of breast infection (pain/swelling)
1 Allergic reaction
Hematoma (n= 2) 2 SSI
1 Seroma
1 Noninfectious wound complication (dehiscence/fat or tissue necrosis)
Seroma (n= 4) 1 SSI
3 Hematoma




10 Noninfectious wound complication (fat or tissue necrosis)
2 No wound complication (breast reconstruction/revision, no complication)




11 Noninfectious wound complication (dehiscence/tissue necrosis)
Tissue necrosis (n= 8) 1 SSI
2 Hematoma
3 Noninfectious wound complication (dehiscence/fat necrosis)
1 Non-speciﬁc complication (poorly healing wound)
2 No wound complication (drain removal, no complication)
NOTE. SSI, surgical site infection.
aAn individual record could have multiple complications recorded.
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69% depending on whether cellulitis-alone was considered to
meet the SSI deﬁnition. Cellulitis-alone was excluded from the
NHSN deﬁnition of SSI in 2010,6,7 and this change has had
a considerable impact on reported infection rates because
cellulitis is the most common postoperative breast infection.8
To address this impact, we calculated the PPV for SSI using the
deﬁnition of SSI at the time of the study (2004–2009), as well
as the current NHSN deﬁnition excluding cellulitis-only. Of
the 51 miscoded SSIs (using the strict deﬁnition of SSI),
14 cases were recorded as cellulitis in the medical record, and 3
of the 8 cases miscoded with cellulitis were recorded in the
medical record as an SSI without clinician documentation
of cellulitis.
Most nonconﬁrmed individual complications coded in the
claims were documented in the records as other noninfectious
breast wound complications. Some of the miscodings could
have been due to misinterpretation via term searches. For
example, a common error involving false coding for SSI was
due to the use of the diagnosis code for infected seroma
(998.51), in women with a documented seroma (without
evidence for infection). Similarly, difﬁculty appeared to exist
in discriminating fat necrosis versus tissue necrosis.
These results suggest that care should be used with respect
to the inclusion of certain codes in algorithms to identify
speciﬁc complications (ie, avoid 998.51 for identifying SSIs).
Because the majority of errors in coding noninfectious wound
complications involved misinterpretation of the speciﬁc
complication, it may be better to focus on a composite group
consisting of fat necrosis, tissue necrosis, or dehiscence, which
had a higher PPV. In contrast, the PPVs for seroma and
hematoma were very high; therefore, these can be reliably
identiﬁed as individual complications.
In the literature, validation of claims data for SSI surveil-
lance has yielded mixed results. The sensitivities of algorithms
using a comprehensive list of codes to identify SSI in several
studies were high at 72%–99%,9–11 while the PPVs were lower,
ranging from 15% to 51%.3,10–16 In contrast, in studies that
used a small set of SSI-speciﬁc diagnosis codes,1,2,17–22 sensi-
tivities varied greatly depending on the surgery and the data
source, from 20% for 998.59 from a single academic medical
center after general and vascular surgery18 to 100% after joint
arthroplasty (using 998.5X and 996.66) or vascular surgery
(using 998.5X and 996.62) using Medicare claims.17 The
PPVs in these studies using SSI-speciﬁc codes were generally
higher, with 4 of 6 studies reporting PPVs >50% and up to
88%.1,2,18–21
Only 3 studies have assessed the accuracy of coding for SSI
codes after breast surgery. We previously reported high sensi-
tivity (88%), speciﬁcity (99%), and PPV (88%) for SSI using
ICD-9-CM diagnosis codes 611.0, 682.2, 682.3, 996.69, and
998.5X from primarily inpatient billing data after breast
surgery at an academic medical center.2 In a multicenter
2-phase study, Yokoe et al1 reported the sensitivity of SSI
diagnosis codes 998.5X from inpatient billing data as 50% in
phase 1 and 70% in phase 2, with PPVs of 58% and 79%,
respectively. Miner et al3 used claims data from a large health-
care system to evaluate a complex algorithm for SSI using a
variety of ICD-9-CM diagnosis codes and procedure codes for
wound care and culture. The PPV of the SSI algorithm using
medical claims from inpatient, outpatient, or emergency
department encounters within 60 days after breast surgery
was only 18%.3
The choice of codes used to identify SSIs and corresponding
sensitivity and PPV depends on the intended goal of surveil-
lance. Our intent was to develop an algorithm to compare
complication rates among facilities and over time; thus, our
focus was on maximizing the PPV to identify SSI and non-
infectious wound complications. Interestingly, Calderwood
et al12,16 reported low PPVs of a comprehensive list of diag-
nosis and procedure codes used to identify SSIs in Medicare
claims after hip arthroplasty and vascular surgery, but they
found similar PPVs between hospitals in the best- and worst-
performing deciles in terms of risk-adjusted infection rates.
These ﬁndings highlight the potential beneﬁt of administrative
data for comparing SSI rates between hospitals, even when
PPVs are low.
The PPVs for the procedure codes to identify mastectomy
and breast implant and autologous ﬂap reconstruction were all
>97%, consistent with previous reports.2,23,24 As described
previously,4 before randomly selecting procedures for medical
record review, we performed extensive ﬁltering to exclude
procedures that were unlikely mastectomy (eg, mastectomy
coded only by an assistant, brachytherapy catheters at time of
procedure). Thus, the true PPVs of the procedures codes for
mastectomy and reconstruction procedures are likely lower
than we report. Provided that a comprehensive algorithm is
used to identify the appropriate patient population, the high
PPVs of procedure codes suggest that accurate denominators
can be calculated from claims or billing data to compare SSI
rates across different surgical procedures or institutions.
We are aware of some limitations in our study. First, we only
reviewed the record from 1 source (facility or provider) per
patient, so it is possible that documentation of a complication
may have been available in an alternative record. We could
only determine the PPV of the ICD-9-CM diagnosis code
algorithms and not sensitivity, speciﬁcity, or negative
predictive values because we did not obtain medical records
for women who were not coded for complications. A larger
study would be helpful to assess whether our ﬁndings for
individual noninfectious complications can be replicated.
Using health claims data, we captured complications coded
at the time of an inpatient or outpatient hospital visit at the
same or different institution than the index mastectomy, as
well as complications treated in outpatient clinics. We found
moderate PPVs for ICD-9-CM diagnosis codes for fat necrosis,
tissue necrosis, and dehiscence, and we found high PPVs for
coding of cellulitis, hematoma, and seroma. The PPV was
modest for SSI without cellulitis, but it improved when
cellulitis-only was considered an infection and when the
code for infected seroma was excluded from the algorithm.
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Given the relatively high PPVs for noninfectious complica-
tions, including noninfectious wound complications along
with SSI, may provide a more robust measure of quality of care
by which to compare complication rates between facilities.
New surveillance algorithms to identify infectious and non-
infectious wound complications must be developed using
ICD-10 codes in future, but this study can be used as the basis
to develop ICD-10 algorithms. Finally, the high PPVs for
identifying breast procedures are encouraging because they
indicate high accuracy of the denominators used to calculate
wound complication rates from claims data. Although imper-
fect, claims data can be used to screen for possible complica-
tions, with subsequent conﬁrmation by medical record review,
to improve the efﬁciency of routine SSI surveillance.
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